HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyransLaninamivir
Chemical structure of CAS 203120-17-6

Laninamivir

In Stock•Starting at $128 for 25 mg•Purity ≥ 98%
CAS No.203120-17-6
MDL No.N/A
MFC13H22N4O7
MW346.34
InChI KeyQNRRHYPPQFELSF-CNYIRLTGSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 mg98%$128In Stock
50 mg98%$215In Stock
100 mg98%$363In Stock
250 mg98%$614In Stock
1 g98%$1654In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Laninamivir is an acetamide.

CAS No.203120-17-6
Product NameLaninamivir
Heavy Atom Count24Rotatable Bond Count7
Atom Stereo Count5Bond Stereo Count0
HBA7HBD6
TPSA189.720 ŲCharge0
Exact Mass346.14885Complexity532.41
pKa2.195XLogP-3.131

Related Articles

Studies related to this compound and its mechanism of action

Assessment of the effects of renal impairment on the pharmacokinetic profile of laninamivir, a novel neuraminidase inhibitor, after a single inhaled dose of its Prodrug, CS-8958.

Journal of clinical pharmacology • Vol. 51, Issue 2 • 2011
PMID: 20197485DOI: 10.1177/0091270010361914

Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers.

Journal of clinical pharmacology • Vol. 50, Issue 11 • 2010
PMID: 20145259DOI: 10.1177/0091270009356297

Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 40, Issue 3 • 2010
PMID: 20146556DOI: 10.3109/00498250903447691

[Present and future in development of new anti-influenza drugs].

Nihon rinsho. Japanese journal of clinical medicine • Vol. 68, Issue 9 • 2010
PMID: 20845748

Documentation

Similar Products